Patent Number: 6,254,860

Title: Ocular treatment using cyclosporin-A derivatives

Abstract: A method of treating a disorder in an eye, for example, an aqueous deficient dry eye state, phacoanaphylactic endophthalmitis, or uveitis, is provided. The method generally includes administering a therapeutically effective amount of a certain cyclosporin A derivative topically to the affected eye. The derivative may be administered as a solution, suspension or ointment in a pharmaceutically acceptable excipient.

Inventors: Garst; Michael E. (Newport Beach, CA)

Assignee: Allergan Sales, Inc.

International Classification: A61K 38/12 (20060101); A61K 38/13 (20060101); A61K 9/00 (20060101); A61K 031/74 ()

Expiration Date: 07/03/2018